Biosynthesis of Lysosomally Escaped Apoptotic Bodies Inhibits Inflammasome Synthesis in Macrophages

Hyperglycemia and bacterial colonization in diabetic wounds aberrantly activate Nod-like receptor protein 3 (NLRP3) in macrophages, resulting in extensive inflammatory infiltration and impaired wound healing. Targeted suppression of the NLRP3 inflammasome shows promise in reducing macrophage inflamm...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiayi Mao, Wenzheng Xia, Yanglin Wu, Minxiong Li, Yun Zhao, Peisong Zhai, Yuguang Zhang, Tao Zan, Wenguo Cui, Xiaoming Sun
Format: Article
Language:English
Published: American Association for the Advancement of Science (AAAS) 2025-01-01
Series:Research
Online Access:https://spj.science.org/doi/10.34133/research.0581
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832590787849748480
author Jiayi Mao
Wenzheng Xia
Yanglin Wu
Minxiong Li
Yun Zhao
Peisong Zhai
Yuguang Zhang
Tao Zan
Wenguo Cui
Xiaoming Sun
author_facet Jiayi Mao
Wenzheng Xia
Yanglin Wu
Minxiong Li
Yun Zhao
Peisong Zhai
Yuguang Zhang
Tao Zan
Wenguo Cui
Xiaoming Sun
author_sort Jiayi Mao
collection DOAJ
description Hyperglycemia and bacterial colonization in diabetic wounds aberrantly activate Nod-like receptor protein 3 (NLRP3) in macrophages, resulting in extensive inflammatory infiltration and impaired wound healing. Targeted suppression of the NLRP3 inflammasome shows promise in reducing macrophage inflammatory disruptions. However, challenges such as drug off-target effects and degradation via lysosomal capture remain during treatment. In this study, engineered apoptotic bodies (BHB-dABs) derived from adipose stem cells loaded with β-hydroxybutyric acid (BHB) were synthesized via biosynthesis. These vesicles target M1-type macrophages, which highly express the folic acid receptor in the inflammatory microenvironment, and facilitate lysosomal escape through 1,2-distearoyl-sn-propyltriyl-3-phosphatidylethanolamine–polyethylene glycol functionalization, which may enhance the efficacy of NLRP3 inhibition for managing diabetic wounds. In vitro studies demonstrated the biocompatibility of BHB-dABs, their selective targeting of M1-type macrophages, and their ability to release BHB within the inflammatory microenvironment via folic acid and folic acid receptor signaling. These nanovesicles exhibited lysosomal escape, anti-inflammatory, mitochondrial protection, and endothelial cell vascularization properties. In vivo experiments demonstrated that BHB-dABs enhance the recovery of diabetic wound inflammation and angiogenesis, accelerating wound healing. These functionalized apoptotic bodies efficiently deliver NLRP3 inflammasome inhibitors using a dual strategy of targeting macrophages and promoting lysosomal escape. This approach represents a novel therapeutic strategy for effectively treating chronic diabetic wounds.
format Article
id doaj-art-f900d2f49b5b4407af7967d15b6cfefb
institution Kabale University
issn 2639-5274
language English
publishDate 2025-01-01
publisher American Association for the Advancement of Science (AAAS)
record_format Article
series Research
spelling doaj-art-f900d2f49b5b4407af7967d15b6cfefb2025-01-23T08:00:57ZengAmerican Association for the Advancement of Science (AAAS)Research2639-52742025-01-01810.34133/research.0581Biosynthesis of Lysosomally Escaped Apoptotic Bodies Inhibits Inflammasome Synthesis in MacrophagesJiayi Mao0Wenzheng Xia1Yanglin Wu2Minxiong Li3Yun Zhao4Peisong Zhai5Yuguang Zhang6Tao Zan7Wenguo Cui8Xiaoming Sun9Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, P. R. China.Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, P. R. China.Department of Orthopaedics, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, P. R. China.Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, P. R. China.Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, P. R. China.Department of Oral and Maxillofacial-Head & Neck Oncology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, P. R. China.Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, P. R. China.Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, P. R. China.Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, P. R. China.Hyperglycemia and bacterial colonization in diabetic wounds aberrantly activate Nod-like receptor protein 3 (NLRP3) in macrophages, resulting in extensive inflammatory infiltration and impaired wound healing. Targeted suppression of the NLRP3 inflammasome shows promise in reducing macrophage inflammatory disruptions. However, challenges such as drug off-target effects and degradation via lysosomal capture remain during treatment. In this study, engineered apoptotic bodies (BHB-dABs) derived from adipose stem cells loaded with β-hydroxybutyric acid (BHB) were synthesized via biosynthesis. These vesicles target M1-type macrophages, which highly express the folic acid receptor in the inflammatory microenvironment, and facilitate lysosomal escape through 1,2-distearoyl-sn-propyltriyl-3-phosphatidylethanolamine–polyethylene glycol functionalization, which may enhance the efficacy of NLRP3 inhibition for managing diabetic wounds. In vitro studies demonstrated the biocompatibility of BHB-dABs, their selective targeting of M1-type macrophages, and their ability to release BHB within the inflammatory microenvironment via folic acid and folic acid receptor signaling. These nanovesicles exhibited lysosomal escape, anti-inflammatory, mitochondrial protection, and endothelial cell vascularization properties. In vivo experiments demonstrated that BHB-dABs enhance the recovery of diabetic wound inflammation and angiogenesis, accelerating wound healing. These functionalized apoptotic bodies efficiently deliver NLRP3 inflammasome inhibitors using a dual strategy of targeting macrophages and promoting lysosomal escape. This approach represents a novel therapeutic strategy for effectively treating chronic diabetic wounds.https://spj.science.org/doi/10.34133/research.0581
spellingShingle Jiayi Mao
Wenzheng Xia
Yanglin Wu
Minxiong Li
Yun Zhao
Peisong Zhai
Yuguang Zhang
Tao Zan
Wenguo Cui
Xiaoming Sun
Biosynthesis of Lysosomally Escaped Apoptotic Bodies Inhibits Inflammasome Synthesis in Macrophages
Research
title Biosynthesis of Lysosomally Escaped Apoptotic Bodies Inhibits Inflammasome Synthesis in Macrophages
title_full Biosynthesis of Lysosomally Escaped Apoptotic Bodies Inhibits Inflammasome Synthesis in Macrophages
title_fullStr Biosynthesis of Lysosomally Escaped Apoptotic Bodies Inhibits Inflammasome Synthesis in Macrophages
title_full_unstemmed Biosynthesis of Lysosomally Escaped Apoptotic Bodies Inhibits Inflammasome Synthesis in Macrophages
title_short Biosynthesis of Lysosomally Escaped Apoptotic Bodies Inhibits Inflammasome Synthesis in Macrophages
title_sort biosynthesis of lysosomally escaped apoptotic bodies inhibits inflammasome synthesis in macrophages
url https://spj.science.org/doi/10.34133/research.0581
work_keys_str_mv AT jiayimao biosynthesisoflysosomallyescapedapoptoticbodiesinhibitsinflammasomesynthesisinmacrophages
AT wenzhengxia biosynthesisoflysosomallyescapedapoptoticbodiesinhibitsinflammasomesynthesisinmacrophages
AT yanglinwu biosynthesisoflysosomallyescapedapoptoticbodiesinhibitsinflammasomesynthesisinmacrophages
AT minxiongli biosynthesisoflysosomallyescapedapoptoticbodiesinhibitsinflammasomesynthesisinmacrophages
AT yunzhao biosynthesisoflysosomallyescapedapoptoticbodiesinhibitsinflammasomesynthesisinmacrophages
AT peisongzhai biosynthesisoflysosomallyescapedapoptoticbodiesinhibitsinflammasomesynthesisinmacrophages
AT yuguangzhang biosynthesisoflysosomallyescapedapoptoticbodiesinhibitsinflammasomesynthesisinmacrophages
AT taozan biosynthesisoflysosomallyescapedapoptoticbodiesinhibitsinflammasomesynthesisinmacrophages
AT wenguocui biosynthesisoflysosomallyescapedapoptoticbodiesinhibitsinflammasomesynthesisinmacrophages
AT xiaomingsun biosynthesisoflysosomallyescapedapoptoticbodiesinhibitsinflammasomesynthesisinmacrophages